Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04369924 · ClinicalTrials.gov registry record · NA
Personalized Assessment of Client Experiences
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 1,261
- Enrollment target
NCT04369924: Completed NA study, sponsored by University of Miami.
NCT04369924 is a NA study that has completed, run by University of Miami. The registered enrollment target is 1,261 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04369924, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,261 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two clinical approaches to youth mental health care.
Primary Outcome
A youth-report measure of youth symptoms ranging from 0 to 100, with higher scores indicating higher general mental health symptoms.
Interventions
- BEHAVIORAL Unidimensional Measurement-Based Care
- BEHAVIORAL Multidimensional Measurement-Based Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,261 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
What the finished NCT04369924 record still lists
NCT04369924 is an interventional study that assigns participants to a tested intervention. Its 1,261 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% lower).
The record links to 0 conditions, and to 2 interventions - of which Unidimensional Measurement-Based Care is the first listed.
NCT04369924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04369924 about?
NCT04369924 is a clinical study titled "Personalized Assessment of Client Experiences". The purpose of this study is to compare two clinical approaches to youth mental health care.
What is the current status of trial NCT04369924?
This trial is currently completed. It is a NA study. The enrollment target is 1,261 participants. The study started on 2020-11-01. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT04369924?
The interventions under investigation include: Unidimensional Measurement-Based Care (BEHAVIORAL), Multidimensional Measurement-Based Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT04369924?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04369924's enrollment target sits among peer trials
1,261 79th of 2000 higher than 1,922 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- NCT06812273 · 1,260 participants · NA
Mediators and Moderators of Auditory Training
- NCT06931340 · 1,260 participants · Phase 3
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- NCT06119581 · 1,264 participants · Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI